Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Enfermedad de Parkinson

2601 ARTíCULOS , VIENDO DEL 2521 AL 2535

PUBMED

Poly (ADP-ribose) in the pathogenesis of Parkinson's disease.

Lee Y, Kang HC, Lee BD, Lee YI, Kim YP, Shin JH.

BMB Rep. 2014 Aug;47(8):424-32. Review.

0

0

0

PUBMED

Transnitrosylation from DJ-1 to PTEN attenuates neuronal cell death in parkinson's disease models.

Choi MS, Nakamura T, Cho SJ, Han X, Holland EA, Qu J, Petsko GA, Yates JR 3rd, Liddington RC, Lipton SA.

J Neurosci. 2014 Nov 5;34(45):15123-31. doi: 10.1523/JNEUROSCI.4751-13.2014.

0

0

0

PUBMED

Pain in Parkinson's disease associated with COMT gene polymorphisms.

Li W, Chen Y, Yin B, Zhang L.

Behav Neurol. 2014;2014:304203. doi: 10.1155/2014/304203.

0

0

0

PUBMED

Parkinson Disease Genetics: A Continuum" From Mendelian to Multifactorial Inheritance."

Petrucci S, Consoli F, Valente EM.

Curr Mol Med. 2014 Oct 10. [Epub ahead of print]

0

0

0

PUBMED

Two-step grafting significantly enhances the survival of foetal dopaminergic transplants and induces graft-derived vascularisation in a 6-OHDA model of Parkinson's disease.

Büchele F, Döbrössy M, Hackl C, Jiang W, Papazoglou A, Nikkhah G.

Neurobiol Dis. 2014 Aug;68:112-25. doi: 10.1016/j.nbd.2014.04.009.

0

0

0

PUBMED

Continuous infusion of levodopa-carbidopa intestinal gel in Parkinson's disease.

Guthikonda LN, Lyons KE, Pahwa R.

J Comp Eff Res. 2014 Jul;3(4):331-3. doi: 10.2217/cer.14.33.

0

0

0

PUBMED

β-Amyloid in CSF: a window into Parkinson disease dementia.

Siderowf A, Logroscino G.

Neurology. 2014 May 20;82(20):1758-9. doi: 10.1212/WNL.0000000000000437. No abstract available.

0

0

0

PUBMED

Jejunal levodopa infusion in Parkinson's disease.

Rascol O.

Lancet Neurol. 2014 Feb;13(2):128-9. doi: 10.1016/S1474-4422(13)70291-6. No abstract available.

0

0

0

PUBMED

Evaluation of mild cognitive impairment subtypes in Parkinson's disease.

Cholerton BA, Zabetian CP, Wan JY, Montine TJ, Quinn JF, Mata IF, Chung KA, Peterson A, Espay AJ, Revilla FJ, Devoto J, Watson GS, Hu SC, Leverenz JB, Edwards KL.

Mov Disord. 2014 May;29(6):756-64. doi: 10.1002/mds.25875.

0

0

0

PUBMED

VMAT2 and Parkinson's disease: harnessing the dopamine vesicle.

Lohr KM, Miller GW.

Expert Rev Neurother. 2014 Oct;14(10):1115-7. doi: 10.1586/14737175.2014.960399.

0

0

0

PUBMED

Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson's disease.

Yue X, Hariri DJ, Caballero B, Zhang S, Bartlett MJ, Kaut O, Mount DW, Wüllner U, Sherman SJ, Falk T.

Neuroscience. 2014 Jan 31;258:385-400. doi: 10.1016/j.neuroscience.2013.11.038.

0

0

0

PUBMED

Protocol for a randomized comparison of integrated versus consecutive dual task practice in Parkinson's disease: the DUALITY trial.

Strouwen C, Molenaar EA, Keus SH, Münks L, Munneke M, Vandenberghe W, Bloem BR, Nieuwboer A.

BMC Neurol. 2014 Mar 27;14:61. doi: 10.1186/1471-2377-14-61.

0

0

0

PUBMED

Treatment of the motor and non-motor symptoms in Parkinson's disease according to cluster symptoms presentation.

Lauretani F, Saginario A, Ceda GP, Galuppo L, Ruffini L, Nardelli A, Maggio M.

Curr Drug Targets. 2014;15(10):943-7.

0

0

0

PUBMED

Parkinson's disease patients first treated at age 75 years or older: a comparative study.

Peretz C, Chillag-Talmor O, Linn S, Gurevich T, El-Ad B, Silverman B, Friedman N, Giladi N.

Parkinsonism Relat Disord. 2014 Jan;20(1):69-74. doi: 10.1016/j.parkreldis.2013.09.020.

0

0

0

PUBMED

Serum uric acid and risk of dementia in Parkinson's disease.

González-Aramburu I, Sánchez-Juan P, Sierra M, Fernández-Juan E, Sánchez-Quintana C, Berciano J, Combarros O, Infante J.

Parkinsonism Relat Disord. 2014 Jun;20(6):637-9. doi: 10.1016/j.parkreldis.2014.02.023.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy